Dialysis market expected to reach $129.8 Billion by 2028

According to a new report published by Allied Market Research, titled, “Dialysis market by Type, Product & Service, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2028," the global dialysis market was valued at $91.2 billion in 2020, and is projected to reach $129.8 billion by 2028, registering a CAGR of 4.7%. North America is the highest contributor in the dialysis market; however, Asia-Pacific is expected to witnessed the highest growth rate during the forecast period 

The function of the kidney is to remove waste products and excess fluid from the blood. This process is carried out with the help of dialysis when the kidney is not functioning properly. Waste products, such as urea and creatinine, are removed from the blood with the help of artificial and natural semipermeable membranes. In hemodialysis, the blood is purified using an artificial membrane, whereas, in peritoneal dialysis, the waste products are removed using peritoneum in abdomen, which acts as a natural semi-permeable membrane.

The major driving factors for the growth of dialysis market include increase in number of end-stage renal diseases, rise in incidences of diabetes and hypertension, and surge in funding for development of new products. In addition, growth in healthcare expenditure, rise in aged population, and increase in disposable income are expected to boost the market growth. Moreover, owing to lack of matching donors, dialysis treatment is preferred over kidney transplant, which is expected to further fuel the market growth. However, lack of awareness about kidney diseases, product recall, and reduction in reimbursements for dialysis are expected to hamper the market growth.

The dialysis market is segmented on the basis of type, Product & Service, end user, and region. On the basis of type, it is bifurcated into hemodialysis and peritoneal dialysis. Hemodialysis is categorized into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is further classified into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). On the basis of Product & Service, it is divided into equipment, consumables, drugs, and services. Equipment is further categorized into dialysis machines, water treatment systems, and others. Consumables are classified into dialyzers, catheters, and transfer sets. On the basis of end users, it is bifurcated into in-center dialysis and home dialysis. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By type, the hemodialysis segment is the major contributor toward market growth, owing to the maturity of the market and it being the preferred form of approach among healthcare professionals and patients suffering from ESRD. Majority of patients opt for hemodialysis, however, owing to efficient removal of toxic substances and rise in demand for homecare among dialysis patients, peritoneal dialysis is expected to be the fastest growing segment during the forecast period. By dialysis site, most patients prefer to receive dialysis treatments through services provided by dialysis centers making them the largest revenue contributors to the global market. Nonetheless, rise in awareness and surge in demand for home healthcare among dialysis patients is expected to boost the growth of the home dialysis segment during the forecast period.

By product & service, the services segment was the highest contributor toward market growth in 2020 and is expected to maintain its dominance during the forecast period. Increase in number of treatment centers and advancement of home-based services are the factors attributing toward the dominance of the services segment.

In 2020, North America accounted for maximum contribution to the total revenue generated owing to the high prevalence rate of diabetes and hypertension, presence of high disposable income, and high adoption rate of technologically advanced products. Moreover, the presence of large number of dialysis centers in this region and a rise in the number of patients with chronic renal and kidney diseases are expected to boost the market growth. However, the Asia-Pacific region is expected to witness the highest CAGR during the analysis period, which is attributed to a surge in the incidence rate of kidney failure, low rate of organ transplantation, and rise in healthcare expenditure.

Key Findings Of The Study 

• The peritoneal dialysis segment is anticipated to grow at the highest rate during the analysis period.
• The hemodialysis segment generated the highest revenue in 2020, and is expected to continue its dominance in the near future.
• North America dominated global dialysis market in 2020, and is anticipated to continue its dominance in the future.
• China is expected to grow at a highest rate in the Asia-Pacific during the forecast period.
• The services segment was the highest contributor among the Product & Service segments in 2020.

The key players operating in the global dialysis market include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., Nipro Corporation, B Braun Melsungen Ag, Nikkiso Co., Ltd., Becton, Dickinson And Company (C. R. Bard, Inc.), Angiodynamics Inc., Asahi Kasei Corp., Davita, and Diaverum Deutschland GmbH.